[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-256886-105":53,"doc-detail-256886-en":127},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":120,"head_meta":122,"extra_data":124,"updated_unix":126},105,"en","mifemiso-participant-interview-consent-form-qualitative-icf-v30","MifeMiso - Participant Interview Consent Form (Qualitative ICF v3.0)","","MifeMiso qualitative patient satisfaction interview consent form for a randomized, placebo-controlled trial comparing mifepristone and misoprostol versus misoprostol alone in medical management of missed miscarriage. The form confirms that participants read and understood the patient information leaflet and had questions answered. It explains voluntary participation, the right to withdraw without affecting treatment or legal rights, and how collected information will be anonymised for medical research. It also covers audio recording, secure storage, confidential transcription under the Data Protection Act 1998, and anonymous use of quotes in publications.",{"@graph":63,"@context":119},[64,80,102],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":36,"@type":70,"position":76},"https://docshare.wps.com/template/forms/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/mifemiso-participant-interview-consent-form-qualitative-icf-v30/256886/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/mifemiso-participant-interview-consent-form-qualitative-icf-v30/256886.png","ImageObject",442,249,{"name":88,"@type":89},"Ava Thompson","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-10-23","2026-09-13",true,{"@type":98,"interactionType":99,"userInteractionCount":101},"InteractionCounter",{"@type":100},"ViewAction",10,{"@type":103,"mainEntity":104},"FAQPage",[105,111,115],{"name":106,"@type":107,"acceptedAnswer":108},"What does the participant confirm before agreeing to the interview?","Question",{"text":109,"@type":110},"The participant confirms they have read and understood the patient information leaflet, had the opportunity to ask questions, and received satisfactory answers.","Answer",{"name":112,"@type":107,"acceptedAnswer":113},"Can a participant withdraw from the interview, and will it affect treatment or legal rights?",{"text":114,"@type":110},"Participation is voluntary. The participant may withdraw at any time without giving a reason, and without treatment or legal rights being affected.",{"name":116,"@type":107,"acceptedAnswer":117},"How are interview recordings and quotes handled for research and publications?",{"text":118,"@type":110},"The interview can be audio-recorded, with recordings kept safe at the University of Birmingham and treated as confidential under the Data Protection Act 1998. Transcription is handled by a specialist company under the same act, and quotes may be used anonymously in publications.","https://schema.org",{"og:url":78,"og:type":121,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":123,"canonical":78},"index,follow",{"doc_id":125,"site_id":56},256886,1789308612,{"code":4,"msg":5,"data":128},{"doc_id":125,"user_id":129,"nickname":88,"user_avatar":130,"doc_module":9,"category_id":35,"category_name":36,"doc_title":59,"doc_description":61,"doc_content":131,"file_id":132,"file_url":133,"file_type":134,"file_size":135,"view_count":101,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":9,"language":136,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":137,"faqs":138,"seo_title":139,"seo_description":61,"update_tm":126,"read_time":4},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","Participant trial number:  \n\n|  |  |  |  |\n| --- | --- | --- | --- |\n\nMifeMiso: A randomised placebo-controlled trial of mifepristone and misoprostol versus misoprostol alone in the medical management of missed miscarriage  \nPatient Satisfaction Interview Study  \nPARTICIPANT INTERVIEW CONSENT FORM  \nChief Investigator: Professor Arri Coomarasamy  \nInitial each box to confirm consent  \nI confirm that I have read and understand the patient information leaflet (version   , dated   /   /   ) for the MifeMiso Patient Satisfaction Interview Study. I have had the opportunity to ask questions and these have been answered satisfactorily.  \nI understand that my participation in an interview is voluntary and I am free to withdraw at any time, without giving areason and without my treatment or legal rights being affected.  \nI understand that the information collected will be used for medical research only and that I will not be identified in anyway in the analysis and reporting of the results. I understand that even if I withdraw from the study, information already collected about me may be included in the final study analysis after being anonymised.  \nI agree to the interview being audio-recorded and understand that the recordings will be kept safe at the University of Birmingham and that everything I say will be kept confidential in accordance with the Data Protection Act 1998.  \nI understand that the transcription of the audio-recording will be done by a specialist transcription company, and will be handled in accordance with the Data Protection Act 1998.  \nI agree that quotes from the interview can be used anonymously in any publication of the research findings.  \nI understand that researchers for the MifeMiso Patient Satisfaction Interview Study based at my hospital or at the University of Birmingham may contact me by telephone, mobile telephone, post or e-mail to request information.  \nI understand the information that I have been given about the MifeMiso Patient Satisfaction Interview Study and I agree to take part.  \nName of Participant:   Date:   Signature:   Name of Researcher:   Date:   Signature:    \nMaster copy for MifeMiso Trial Office, 1 copy for Participant, 1 copy for qualitative researcher","cbCaiaWnTkzmsNHx","https://ap.wps.com/l/cbCaiaWnTkzmsNHx","pdf",243629,"English","# PARTCIPANT INTERVIEW CONSENT FORM\n## Consent confirmation and understanding\n## Voluntary participation and withdrawal\n## Use of collected information and confidentiality\n## Audio recording, transcription, and anonymous quotes","[{\"question\":\"What does the participant confirm before agreeing to the interview?\",\"answer\":\"The participant confirms they have read and understood the patient information leaflet, had the opportunity to ask questions, and received satisfactory answers.\"},{\"question\":\"Can a participant withdraw from the interview, and will it affect treatment or legal rights?\",\"answer\":\"Participation is voluntary. The participant may withdraw at any time without giving a reason, and without treatment or legal rights being affected.\"},{\"question\":\"How are interview recordings and quotes handled for research and publications?\",\"answer\":\"The interview can be audio-recorded, with recordings kept safe at the University of Birmingham and treated as confidential under the Data Protection Act 1998. Transcription is handled by a specialist company under the same act, and quotes may be used anonymously in publications.\"}]","MifeMiso - Participant Interview Consent Form (Qualitative ICF v3.0) | PDF"]